WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

Acquisition

DePuy Synthes buys Expanding Innovations and its screw-free spine cages

MedDevice Startups Staff · Jul 16 · 2 min read · Via MedTech Dive

DePuy Synthes, the Johnson & Johnson orthopaedics business preparing for its spinoff from J&J, agreed on July 16, 2026 to acquire Expanding Innovations. Terms were not disclosed.

Expanding Innovations makes expandable interbody cages for lumbar fusion that lock without screws and are designed to resist cage collapse and vertebral subsidence. Its current devices cover transforaminal and lateral lumbar interbody fusion, with anterior lumbar interbody fusion planned next.

DePuy said the purchase strengthens its spine portfolio and its position in the expandable interbody cage segment, and that the technology will complement its existing spine systems and integrate with the Velys robotic platform. A tuck-in like this one is the most common exit in orthopaedics: a differentiated implant, a buyer with a robot that needs implants to drive, and no price disclosed.

Questions & Answers

What did DePuy Synthes acquire from Expanding Innovations?

Expandable interbody cage technology for lumbar fusion that locks without screws and is designed to prevent cage collapse and vertebral subsidence, covering transforaminal and lateral lumbar interbody fusion today.

How much did DePuy Synthes pay for Expanding Innovations?

The price and terms were not disclosed when the deal was announced on July 16, 2026.

Why does the deal matter to DePuy Synthes?

DePuy said it strengthens its spine portfolio and its position in expandable interbody cages, and the implants are expected to integrate with its Velys robotic platform as the business prepares to spin off from Johnson & Johnson.

← Back to M&A